REGN
Regeneron Pharmaceuticals Inc
Price:  
1,036.52 
USD
Volume:  
353,226.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Relative Valuation

-38.6%
Upside

As of 2024-06-17, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 636.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1,036.52 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is -38.6%.

The range of the Relative Valuation is 530.44 - 670.10 USD.

Range Selected
Trailing P/E multiples 16.1x - 19.1x 18.7x
Forward P/E multiples 15.3x - 19.2x 17.9x
Fair Price 530.44 - 670.10 636.83
Upside -48.8% - -35.4% -38.6%
1,036.52 USD
Stock Price
636.83 USD
Fair Price

Regeneron Relative Valuation - Historical P/E Data

Date P/E
2024-06-17 29.91
2024-06-14 29.61
2024-06-13 29.32
2024-06-12 29.35
2024-06-11 28.86
2024-06-10 28.61
2024-06-07 28.65
2024-06-06 28.59
2024-06-05 28.73
2024-06-04 28.37
2024-06-03 28.26
2024-05-31 28.00
2024-05-30 27.70
2024-05-29 27.61
2024-05-28 27.80
2024-05-24 28.14
2024-05-23 28.01
2024-05-22 28.10
2024-05-21 28.39
2024-05-20 28.20
2024-05-17 28.06
2024-05-16 27.65
2024-05-15 27.94
2024-05-14 28.12
2024-05-13 27.90
2024-05-10 27.81
2024-05-09 27.65
2024-05-08 27.30
2024-05-07 27.71
2024-05-06 27.38
2024-05-03 27.33
2024-05-02 26.78
2024-05-01 25.81
2024-04-30 25.44
2024-04-29 25.49
2024-04-26 25.23
2024-04-25 25.44
2024-04-24 25.89
2024-04-23 25.92
2024-04-22 25.71
2024-04-19 25.62
2024-04-18 25.53
2024-04-17 25.74
2024-04-16 25.54
2024-04-15 25.67
2024-04-12 25.84
2024-04-11 26.29
2024-04-10 26.74
2024-04-09 26.96
2024-04-08 26.81